Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
- Simon J. Bowman
- , Raphaele Seror
- , Raphael Porcher
- , Suzanne Arends
- , Liseth de Wolff
- , Gwenny Verstappen
- , Valerie Devauchelle-Pensec
- , Sandrine Jousse-Joulin
- , Chiara Baldini
- , Michele Bombardieri
- , Elena Pontarini
- , Wolfgang Hueber
- , Jessica Marvel
- , Pushpendra Goswami
- , Divi Cornec
- , Benjamin A. Fisher
- , Saba Nayar
- , Francesca Barone
- , Wan Fai Ng
- , Jacques Eric Gottenberg
- University Hospitals Birmingham NHS Foundation Trust
- University of Birmingham
- National Institute for Health and Care Research
- Milton Keynes University Hospital NHS Foundation Trust
- Université Paris-Saclay
- Assistance publique – Hôpitaux de Paris
- Université Paris Cité
- University of Groningen
- CHU de Brest
- University of Pisa
- Queen Mary University of London
- Novartis
- Newcastle University
- Strasbourg University Hospital
- Institut de Biologie Moléculaire et Cellulaire (IBMC)
- Charité – Universitätsmedizin Berlin
- Association Française du Gougerot Sjögren
- Sjögren Europe
- Sjögren's Foundation
- Karolinska Institutet
- Utrecht University
- Institut de Recherches Servier
- Bristol-Myers Squibb
- Cullinan Therapeutics
- GlaxoSmithKline
- University of Bergen
- Université Paris Sud
Research output: Contribution to journal › Review article › peer-review